← Back to patent-cliff list
盐酸坦洛新
Tier C — Watch / tradeTamsulosin Hydrochloride
安斯泰来制药集团
Originator
1993
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：ADRA1A
Brand：齐索、Alna、哈乐、Flomax、Omnic、Contiflo XL、Omix、Harnal、必坦、Secotex、积大本特、Flomaxtra、Josir、Harnal D、Pradif、Harnalidge OCAS、Hanmi Tams、Urolosin、AlnaOCAS、Urimax、Omic、Flomax MR
Indications (approved)：前列腺增生
Regional status
US
临床三期
2008-01-01
EU
临床二期
2006-04-01
China
批准上市
1999-04-03
Japan
批准上市
1993-01-01
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Tamsulosin Hydrochloride?
Approved indications include: 前列腺增生.
When does the Tamsulosin Hydrochloride patent expire?
No public expiry year is available for Tamsulosin Hydrochloride yet; this page updates once verified.
How do I get a quote for Tamsulosin Hydrochloride intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25